Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2015Cell ReportsOpen Access

Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains

View Full Paper
Ask AI
Bookmark
Share

Authors

TSTimothy J. StuhlmillerUniversity of North Carolina at Chapel HillSMSamantha M. MillerSoutheastern UniversityJZJon S. ZawistowskiUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stuhlmiller et al. (2015) studied this question.

synapsesocial.com/papers/6a82903fd5d5076d1fb281fehttps://doi.org/10.1016/j.celrep.2015.03.037
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib2011 · 164 citations
  2. 2Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin2010 · 248 citations
  3. 3Functional Genetic Approach Identifies MET, HER3, IGF1R, INSR Pathways as Determinants of Lapatinib Unresponsiveness in HER2-Positive Gastric Cancer2014 · 70 citations
  4. 4Resiliency and Vulnerability in the HER2-HER3 Tumorigenic Driver2010 · 186 citations
  5. 5BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain2012 · 387 citations